Hydroquinone inhibits PMA-induced activation of NFκB in primary human CD19+ B lymphocytes
Hydroquinone inhibits PMA-induced activation of NFκB in primary human CD19+ B lymphocytes
复制标题
DOI:
10.1023/a:1007644620655
复制
发表时间:
2000-01-01
影响因子:
6.1
通讯作者:
Irons, RD
中科院分区:
文献类型:
--
作者:
Pyatt, DW;Yang, Y;Irons, RD
Hydroquinone (HQ), a reactive metabolite of benzene, is known to inhibit mitogen-stimulated activation of both T and B lymphocytes. Despite extensive study, the underlying mechanism for the immunotoxicity of the HQ is not clear. We have previously demonstrated that 1 mu mol/L HQ inhibits TNF-induced activation of NF kappa B in CD4(+) T cells, resulting in decreased IL-2 production. NF kappa B, known to be important in T lymphocytes, also plays a critical role in normal B cell development and activation. We therefore hypothesized that alterations in NF kappa B might be involved in HQ-induced B cell immunosuppression as well. In this study, we demonstrate that 1-10 mu mol/L HQ inhibits PMA/ionomycin-induced activation of NF kappa B in primary human CD19(+) B cells. Inhibition of NF kappa B is accompanied by a dose-dependent decrease in PMA-stimulated production of TNF with no corresponding loss in viability or increased apoptosis. HQ also does not appear to alter NF kappa B directly, as preincubation of B cell nuclear extracts with HQ does not diminish DNA binding activity of this protein. In contrast to T cells, inhibition of NF kappa B by HQ in B cells is not reversible after 72 h in culture, suggesting a long-term functional suppression. These data support our original findings in T cells and indicate that NF kappa B is particularly susceptible to inhibition by HQ. We further hypothesize that inhibition of NF kappa B in lymphocytes, and perhaps other cell types as well, may play a significant role in the observed toxicity of HQ.